Aged
Brain
/ blood supply
Brain Neoplasms
/ diagnostic imaging
Female
Glioblastoma
/ diagnostic imaging
Humans
Large Neutral Amino Acid-Transporter 1
/ genetics
Magnetic Resonance Imaging
Male
Middle Aged
Multimodal Imaging
Neovascularization, Pathologic
/ diagnostic imaging
Positron-Emission Tomography
Protein Binding
Radiopharmaceuticals
/ pharmacokinetics
Tyrosine
/ analogs & derivatives
18F-Fluorethyltyrosine PET
Amino acid transporter
Glioblastoma
Histopathology
Immunohistochemistry
Neovascularization
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
13
03
2019
accepted:
18
06
2019
pubmed:
11
7
2019
medline:
15
9
2020
entrez:
11
7
2019
Statut:
ppublish
Résumé
To investigate the in vivo correlation between A total of 43 stereotactic biopsies were obtained from 13 patients with suspected glioblastoma prior to therapy. All patients underwent a dynamic In all patients, the final diagnosis was IDH-wildtype glioblastoma, WHO grade IV. Static Our results support the findings of preclinical studies suggesting that specific
Identifiants
pubmed: 31289907
doi: 10.1007/s00259-019-04407-3
pii: 10.1007/s00259-019-04407-3
doi:
Substances chimiques
Large Neutral Amino Acid-Transporter 1
0
Radiopharmaceuticals
0
SLC7A5 protein, human
0
(18F)fluoroethyltyrosine
1326R5J1IA
Tyrosine
42HK56048U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2163-2168Références
Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199–208. https://doi.org/10.1093/neuonc/now058 .
doi: 10.1093/neuonc/now058
pubmed: 27106405
pmcid: 4999003
Habermeier A, Graf J, Sandhofer BF, Boissel JP, Roesch F, Closs EI. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET). Amino Acids. 2015;47:335–44. https://doi.org/10.1007/s00726-014-1863-3 .
doi: 10.1007/s00726-014-1863-3
pubmed: 25385314
Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol. 2011;13:307–16. https://doi.org/10.1093/neuonc/noq196 .
doi: 10.1093/neuonc/noq196
pubmed: 21292686
pmcid: 3064604
Rohrich M, Huang K, Schrimpf D, Albert NL, Hielscher T, von Deimling A, et al. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. Eur J Nucl Med Mol Imaging. 2018;45:1573–84. https://doi.org/10.1007/s00259-018-4009-0 .
doi: 10.1007/s00259-018-4009-0
Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, et al. Voxel-wise analysis of dynamic (18)F-FET PET: a novel approach for non-invasive glioma characterisation. EJNMMI Res. 2018;8:91. https://doi.org/10.1186/s13550-018-0444-y .
doi: 10.1186/s13550-018-0444-y
pubmed: 30203138
pmcid: 6131687
Izquierdo-Garcia D, Hansen AE, Förster S, Benoit D, Schachoff S, Fürst S, et al. An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET/MR brain imaging. J Nucl Med. 2014;55:1825–30. https://doi.org/10.2967/jnumed.113.136341 .
doi: 10.2967/jnumed.113.136341
pubmed: 25278515
pmcid: 4246705
Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Muller HW, et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging. 2003;30:519–24. https://doi.org/10.1007/s00259-003-1118-0 .
doi: 10.1007/s00259-003-1118-0
pubmed: 12589478
Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, et al. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer. 2006;119:484–92. https://doi.org/10.1002/ijc.21866 .
doi: 10.1002/ijc.21866
pubmed: 16496379
Lahoutte T, Caveliers V, Camargo SM, Franca R, Ramadan T, Veljkovic E, et al. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J Nucl Med. 2004;45:1591–6.
pubmed: 15347729
Gottler J, Lukas M, Kluge A, Kaczmarz S, Gempt J, Ringel F, et al. Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma. Eur J Nucl Med Mol Imaging. 2017;44:392–7. https://doi.org/10.1007/s00259-016-3585-0 .
doi: 10.1007/s00259-016-3585-0
pubmed: 27913827
Debus C, Afshar-Oromieh A, Floca R, Ingrisch M, Knoll M, Debus J, et al. Feasibility and robustness of dynamic (18)F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Sci Rep. 2018;8:14760. https://doi.org/10.1038/s41598-018-33034-5 .
doi: 10.1038/s41598-018-33034-5
pubmed: 30283013
pmcid: 6170489
Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, et al. The relationship among hypoxia, proliferation, and outcome in patients with de novo glioblastoma: a pilot study. Transl Oncol. 2010;3:160–9.
doi: 10.1593/tlo.09265
pubmed: 20563257
pmcid: 2887645
Stockhammer F, Plotkin M, Amthauer H, van Landeghem FK, Woiciechowsky C. Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neurooncol. 2008;88:205–10. https://doi.org/10.1007/s11060-008-9551-3 .
doi: 10.1007/s11060-008-9551-3
pubmed: 18317691